Fulcrum Therapeutics (FULC) closed at $3.70 on November 6, 2026, up 0.5% from the previous close, on volume of 816,704 shares (30-day average 1,380,984).
Data as of November 6, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 12-Oct 10:46 PM ET)
Kaplan Fox is Investigating Claims Against Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors
Newsfile (Thu, 8-Oct 4:40 PM ET)
Newsfile (Tue, 6-Oct 6:55 PM ET)
Globe Newswire (Tue, 6-Oct 3:22 PM ET)
Newsfile (Fri, 2-Oct 2:32 PM ET)
Newsfile (Wed, 30-Sep 9:10 AM ET)
Newsfile (Mon, 28-Sep 8:35 AM ET)
Are FULC, TCBK, LXP Obtaining Fair Deals for their Shareholders?
PRNewswire (Fri, 25-Sep 7:40 AM ET)
Newsfile (Thu, 24-Sep 4:50 PM ET)
Globe Newswire (Wed, 23-Sep 9:45 PM ET)
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Fulcrum Therapeutics trades on the NASDAQ stock market under the symbol FULC.
As of November 9, 2026, FULC stock price was flat at $3.70 with 228,709 million shares trading.
FULC has a beta of 1.50, meaning it tends to be more sensitive to market movements. FULC has a correlation of 0.04 to the broad based SPY ETF.
FULC has a market cap of $282.61 million. This is considered a Small Cap stock.
In the last 3 years, FULC traded as high as $15.74 and as low as $2.32.
The top ETF exchange traded funds that FULC belongs to (by Net Assets): VTI, IWM, VXF, IWN, FESM.
FULC has underperformed the market in the last year with a return of -51.6%, while SPY returned +13.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in FULC shares. However, FULC has outperformed the market in the last 3 month and 2 week periods, returning -1.9% and +0.5%, while SPY returned -2.2% and -1.3%, respectively. This indicates FULC has been having a stronger performance recently.
FULC support price is $3.65 and resistance is $3.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FULC shares will trade within this expected range on the day.
